NASDAQ:RMTI Rockwell Medical (RMTI) Stock Price, News & Analysis → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free RMTI Stock Alerts $1.39 -0.01 (-0.71%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$1.36▼$1.4950-Day Range$1.23▼$1.6052-Week Range$1.16▼$6.24Volume160,352 shsAverage Volume177,507 shsMarket Capitalization$39.60 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Rockwell Medical alerts: Email Address Rockwell Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside475.5% Upside$8.00 Price TargetShort InterestHealthy2.52% of Float Sold ShortDividend StrengthN/ASustainability-2.35Upright™ Environmental ScoreNews Sentiment0.51Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.70 out of 5 starsMedical Sector226th out of 947 stocksPharmaceutical Preparations Industry99th out of 434 stocks 3.5 Analyst's Opinion Consensus RatingRockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.00, Rockwell Medical has a forecasted upside of 475.5% from its current price of $1.39.Amount of Analyst CoverageRockwell Medical has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.52% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently increased by 1.65%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRockwell Medical has received a 58.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Iron deficiency medication" and "Clinical research services for deficiency diseases" products. See details.Environmental SustainabilityThe Environmental Impact score for Rockwell Medical is -2.35. Previous Next 3.1 News and Social Media Coverage News SentimentRockwell Medical has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Rockwell Medical this week, compared to 1 article on an average week.Search Interest4 people have searched for RMTI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows2 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.20% of the stock of Rockwell Medical is held by insiders.Percentage Held by InstitutionsOnly 22.07% of the stock of Rockwell Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Rockwell Medical is -2.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rockwell Medical is -2.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 1.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyUrgent new message from Porter StansberryI’ve been in the financial markets for close to three decades… Yet, I’ve never seen an opportunity that’s so urgent, so critical, and yet so overlooked than what is unfolding right now. You see, in one corner of the markets a financial anomaly has emerged that promises to be the single most important story of 2024.Click here now to get what could be the most urgent, and most lucrative research, my team has ever r About Rockwell Medical Stock (NASDAQ:RMTI)Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in patients undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including cleaning agents, 6% bleach for disinfection, citric acid descale, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.Read More RMTI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RMTI Stock News HeadlinesMarch 18, 2024 | markets.businessinsider.comRockwell Medical Inc Registered Shs hosts conference call for investorsMarch 14, 2024 | americanbankingnews.comRockwell Medical (RMTI) Scheduled to Post Quarterly Earnings on ThursdayMarch 19, 2024 | Banyan Hill Publishing (Ad)AI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… February 14, 2024 | finance.yahoo.comRockwell Medical (RMTI) Flat As Market Gains: What You Should KnowFebruary 8, 2024 | finance.yahoo.comRockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024January 23, 2024 | morningstar.comRockwell Medical Inc RMTIJanuary 8, 2024 | msn.comRockwell Medical provides Q4 and fiscal 2023 forecastJanuary 8, 2024 | finance.yahoo.comRockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending FundMarch 19, 2024 | Weiss Ratings (Ad)The ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …December 21, 2023 | benzinga.comRockwell Medical Stock (NASDAQ:RMTI) Dividends: History, Yield and DatesNovember 30, 2023 | seekingalpha.comReturning To Rockwell Medical: Buy At 65% Of RevenueNovember 17, 2023 | finance.yahoo.comRockwell Medical, Inc. (NASDAQ:RMTI): Are Analysts Optimistic?November 17, 2023 | markets.businessinsider.comRockwell Med’s Strong Q3 Results and Strategic Market Maneuvers Drive Positive Analyst RecommendationNovember 15, 2023 | finance.yahoo.comRockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comQ3 2023 Rockwell Medical Inc Earnings CallNovember 14, 2023 | finance.yahoo.comRockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue EstimatesNovember 14, 2023 | finance.yahoo.comRockwell Medical Announces Third Quarter 2023 ResultsNovember 7, 2023 | finance.yahoo.comWhy Rockwell Medical (RMTI) Outpaced the Stock Market TodayOctober 26, 2023 | finance.yahoo.comRockwell Medical (RMTI) Suffers a Larger Drop Than the General Market: Key InsightsOctober 20, 2023 | finance.yahoo.comRockwell Medical (RMTI) Stock Moves -1.18%: What You Should KnowOctober 18, 2023 | finance.yahoo.comRockwell Medical Names Jesse Neri as Senior Vice President, FinanceOctober 16, 2023 | finance.yahoo.comRockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023October 13, 2023 | msn.comWhy Rockwell Medical (RMTI) Dipped More Than Broader Market TodayOctober 4, 2023 | markets.businessinsider.comRockwell Medical’s Growth Prospects Bolstered by Strategic Partnerships and Market Expansion: A Buy RecommendationOctober 3, 2023 | msn.comRockwell Medical enters into product purchase deal with Centers for Dialysis CareOctober 3, 2023 | finance.yahoo.comRockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis CareOctober 2, 2023 | benzinga.comNano-Cap Medical Technology Watchlist (ORHB, BBLG, ICU, RMTI)See More Headlines Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2023Today3/18/2024Next Earnings (Confirmed)3/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:RMTI CUSIP77437410 CIK1041024 Webwww.rockwellmed.com Phone(248) 432-1362Fax248-960-9119Employees253Year Founded1995Price Target and Rating Average Stock Price Target$8.00 High Stock Price Target$11.00 Low Stock Price Target$5.00 Potential Upside/Downside+475.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,680,000.00 Net Margins-11.49% Pretax Margin-11.49% Return on Equity-64.39% Return on Assets-20.90% Debt Debt-to-Equity Ratio0.23 Current Ratio1.32 Quick Ratio1.06 Sales & Book Value Annual Sales$72.81 million Price / Sales0.54 Cash FlowN/A Price / Cash FlowN/A Book Value$1.16 per share Price / Book1.20Miscellaneous Outstanding Shares28,490,000Free Float27,863,000Market Cap$39.60 million OptionableOptionable Beta1.16 Social Links The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Mark Strobeck Ph.D. (Age 53)President, CEO & Director Comp: $643.41kMs. Megan C. Timmins (Age 51)Executive VP, Chief Legal Officer & Secretary Comp: $518.09kMr. Jesse NeriSenior Vice President of FinanceMr. James A. McCarthySenior Vice President of Business & Corporate DevelopmentMr. Timothy T. CholeSenior Vice President of Sales & MarketingMs. Heather R. HunterSenior VP & Chief Corporate Affairs OfficerMr. David J. Kull (Age 56)Secretary Mr. Jason FinkelsteinInvestor Relations RepresentativeMore ExecutivesKey CompetitorsKorro BioNASDAQ:KRROvTv TherapeuticsNASDAQ:VTVTIRIDEXNASDAQ:IRIXNextCureNASDAQ:NXTCEledon PharmaceuticalsNASDAQ:ELDNView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 698,160 shares on 3/11/2024Ownership: 3.773%Vanguard Group Inc.Bought 698,160 shares on 2/15/2024Ownership: 3.773%Citadel Advisors LLCSold 33,100 shares on 2/15/2024Ownership: 0.000%Armistice Capital LLCSold 965,000 shares on 2/13/2024Ownership: 6.501%WealthTrust Axiom LLCBought 10,400 shares on 2/5/2024Ownership: 0.111%View All Institutional Transactions RMTI Stock Analysis - Frequently Asked Questions Should I buy or sell Rockwell Medical stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RMTI shares. View RMTI analyst ratings or view top-rated stocks. What is Rockwell Medical's stock price target for 2024? 2 Wall Street research analysts have issued 12-month price objectives for Rockwell Medical's stock. Their RMTI share price targets range from $5.00 to $11.00. On average, they predict the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 475.5% from the stock's current price. View analysts price targets for RMTI or view top-rated stocks among Wall Street analysts. How have RMTI shares performed in 2024? Rockwell Medical's stock was trading at $1.89 at the beginning of 2024. Since then, RMTI stock has decreased by 26.5% and is now trading at $1.39. View the best growth stocks for 2024 here. When is Rockwell Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024. View our RMTI earnings forecast. How can I listen to Rockwell Medical's earnings call? Rockwell Medical will be holding an earnings conference call on Thursday, March 21st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) issued its earnings results on Tuesday, November, 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.05. The company had revenue of $23.77 million for the quarter, compared to analysts' expectations of $23.67 million. Rockwell Medical had a negative trailing twelve-month return on equity of 64.39% and a negative net margin of 11.49%. During the same quarter in the prior year, the firm earned ($0.40) EPS. When did Rockwell Medical's stock split? Rockwell Medical shares reverse split before market open on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. What guidance has Rockwell Medical issued on next quarter's earnings? Rockwell Medical issued an update on its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $82.8 million-$83.8 million, compared to the consensus revenue estimate of $84.2 million. What is Robert L. Chioini's approval rating as Rockwell Medical's CEO? 6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV). Who are Rockwell Medical's major shareholders? Rockwell Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Armistice Capital LLC (6.50%), Vanguard Group Inc. (3.77%), Vanguard Group Inc. (3.77%), Perkins Capital Management Inc. (1.23%), Raymond James & Associates (0.78%) and WealthTrust Axiom LLC (0.11%). View institutional ownership trends. How do I buy shares of Rockwell Medical? Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RMTI) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.